Dengue virus non-structural 1 protein interacts with heterogeneous nuclear ribonucleoprotein H in human monocytic cells

Objective: To study protein-protein interaction between heterogeneous nuclear ribonucleoprotein H(hn RNP H) and Dengue virus(DENV) proteins. Methods: DENV proteins were screened against the host hn RNP H protein, in order to identify the host-viral protein-protein interactions in DENV infected THP-1 cells by co-immunoprecipitation. The co-localization of the interacting proteins was further confirmed by immunofluorescence microscopy. Results: The host protein hn RNP H was found to interact with DENV nonstructural 1 protein and help the virus to multiply in the cell. Conclusions: The non-structural 1 glycoprotein is a key modulator of host immune response and is also involved in viral replication. Therefore, disruption of this key interaction between hn RNP H and DENV nonstructural 1 could be an important therapeutic strategy for management of DENV infection.

Cleft analysis of Zika virus non-structural protein 1

The non-structural protein 1 is an important molecule of the viruses in flavivirus group including to Zika virus. Recently, the NS1 of Zika virus was discovered. There is still no complete information of the molecular interaction of NS1 of Zika virus which can be the clue for explanation for its pathogenesis and further drug search. Here the authors report the cleft analysis of NS1 of Zika virus and the result can be useful for future development of good diagnostic tool and antiviral drug finding for management of Zika virus.

The cloning of non-structural-1 (NS1) gene of H9N2 subtype of avian influenza virus in pGEX-4T-1 and pMAL-c2X plasmids and expression in <i>Escherichia coli</i>DH5<i>α</i>strain

Avian influenza is a viral contagious disease that affects poultry industry and human health. Vaccination has been considered as a preventive tool in the eradication of AI, but it causes some limitations including trade embargoes and interfering with serologic surveillance in differentiation between infected and vaccinated animals (DIVA strategy). Several distinct DIVA strategies have been presented to conquer these limitations. In this study, the open reading frame of NS1 gene of a H9N2 subtype of AI virus was amplified by polymerase chain reaction. After extraction and purification of NS1 gene from agarose gel, it was inserted into two different pGEX-4T-1 and pMAL-c2X plasmids and transferred in DH5α strain of Escherichia coli by using electroporation procedure. The E. coli colonies possessing recombinant NS1 gene were screened using PCR, restriction mapping and sequencing analysis. The expressed rNS1 protein was purified using affinity chromatography based on MBP (pMAL- c2X) and GST (pGEX-4T-1). The MBP-NS1 and GST- NS1 proteins on SDS-PAGE had bands with molecular weight of 68 and 52 kDa respectively. Western blotting with MBP-NS1 protein showed positive reaction using antisera obtained from chickens challenged with a H9N2 subtype strain. But, the most sera prepared from H9N2 vaccinated chickens were negative in WB. These findings indicated that the MBP-rNS1 protein of 26 kDa expressed by pMAL-c2X plasmid can be used in a DIVA for differentiation of AI infected and vaccinated chickens.

Screening of Proteins Interacting with Nonstructural 1 Protein of H5N1 Avian Influenza Virus from T7-phage Display Library

Avian influenza virus（AIV） nonstructural 1（NS1） gene was amplified by real-time polymerse chain reac tion（RT-PCR） and inserted into pET28a, then transformed into E. coli BL21（DE3） competent cell. With the induction of isopropyl-β-D-thiogalactoside（IPTG） and the purification of Ni-NTA column, we finally obtained purified NS1 protein. T7-phage display system was used to screen the proteins that interacted with NS1 from lung cell cDNA li brary. The selected positive clones were identified by DNA sequencing and analyzed by BLAST program in Gene Bank. Two proteins were obtained as NS1 binding proteins, Homo sapiens nucleolar and coiled-body phosphoprotein 1（NOLC1） and Homo sapiens similar to colon cancer-associated antigen. By co-immunoprecipitation and other me thods, Homo sapiens NOLC1 was found to interact with the NS1 protein, the results would provide the basis for fur ther studying biological function of NS1 protein.

Construction and expression of a synthetic gene encoding nonstructural glycoprotein NS1 of dengue 2 virus in Pichia pastoris

To express and characterize NS1 of Indonesian-specific DENV2 virus in Pichia pastoris (P. pastoris).MethodsA codon optimized synthetic gene derived from the DENV-2 NS1 amino acid sequences was synthesized commercially and inserted into the P. pastoris pPICZαA expression vector. The recombinant DENV-2 NS1 protein was purified by Ni-NTA affinity chromatography, and its antigenicity was tested.ResultsThe recombinant DENV-2 NS1 protein was secreted as a protein with a molecular weight of ∼45 kDa, and the optimal expression condition was achieved by induction with 2% (v/v) methanol for 72 h. The purified recombinant DENV-2 NS1 protein was able to interact with a monoclonal antibody of NS1 in a commercial rapid test.ConclusionsThe resulting recombinant DENV-2 NS1 protein produced in P. pastoris KM71 is a potential candidate for use in the development of a dengue diagnostic kit and vaccine.

猪细小病毒NS1基因的原核表达

根据GenBank发表的猪细小病毒(porcine parvovirus,PPV)中国株基因序列设计引物,通过PCR方法扩增到了PPV LJL12株NS1全长基因,将其克隆到原核表达载pET30a(+)上,成功构建原核表达载体pET30a-NS1,将其转化到大肠杆菌BL21(DE3)感受态细胞。经IPTG诱导表达后,进行SDS-PAGE和Western blot分析。SDS-PAGE电泳显示NS1在大肠杆菌中得到成功表达,重组蛋白大小约为86ku,与预期大小相符;Western blot分析表明,该蛋白能与PPV阳性血清发生特异性反应,证明该蛋白具有良好生物学活性。NS1在大肠杆菌中成功表达,具有免疫原性,可作为鉴别诊断抗原用于PPV的临床检测。

乙型脑炎病毒NS1基因片段的克隆、表达及鉴定

目的构建乙型脑炎病毒NS1基因的重组原核表达质粒,诱导重组蛋白表达及免疫学鉴定。方法以乙型脑炎病毒基因组为模板,RT-PCR扩增NS1基因片段,构建其重组原核表达载体,并采用WesternBlot方法初步鉴定该蛋白的特异性。结果成功扩增出乙型脑炎病毒NS1基因片段,该基因在大肠杆菌表达系统中得到表达,并且特异性识别乙型脑炎患者血清。结论在大肠杆菌中成功表达乙型脑炎病毒NS1基因片段,为乙型脑炎病毒的诊断提供了新的特异性抗原。

乙型脑炎病毒NS1'蛋白移码序列的鉴定

本文通过对猪乙型脑炎病毒(Japanese encephalitis virus,JEV)基因组中移码序列分析,设计合成三条引物,通过PCR扩增出假定的NS1'移码片段,并将移码片段三倍重复克隆入pET-28a表达载体中。重组质粒转化E.coli BL-21后,经IPTG诱导在37℃下实现目的片段的可溶性表达。纯化表达产物,并免疫小鼠制备了多抗血清,以多抗血清为一抗,对JEV感染的Vero细胞进行免疫荧光分析,结果发现抗移码片段表达蛋白的血清可识别JEV蛋白。以JEV感染Vero细胞,提取感染细胞总蛋白,分别以NS1单抗和以上制备的多抗血清为一抗,进行Western blot分析。结果显示,NS1单抗为一抗,可染出48 kDa的NS1条带和56 kDa的NS1'条带;而以多抗血清为一抗,仅染出56 kDa的条带。上述结果显示,多抗血清识别的NS1'蛋白为NS1'移码后片段表达的蛋白。

S-adenosyl-L-methionine modifies antioxidant-enzymes,glutathione-biosynthesis and methionine adenosyltransferases-1/2 in hepatitis C virus-expressing cells

AIM: To elucidate the mechanism(s) by which S-adenosyl-L-methionine(SAM) decreases hepatitis C virus(HCV) expression.METHODS: We examined the effects of SAM on viral expression using an HCV subgenomic replicon cell culture system. Huh7 HCV-replicon cells were treated with 1 mmol/L SAM for different times(24-72 h), then total RNA and proteins were isolated. c DNA was synthesized and real time-PCR was achieved to quantify HCV-RNA, superoxide dismutase 1 and 2(SOD-1, SOD-2) catalase, thioredoxin 1, methionine adenosyltransferase 1A and 2A(MAT1A, MAT2A) expression, and GAPDH and RPS18 as endogenous genes. Expression of cellular and viral protein was evaluated by western-blot analysis using antibodies vs HCV-NS5 A, SOD-1, SOD-2, catalase, thioredoxin-1, MAT1 A, MAT2 A, GAPDH and actin. Total glutathione levels were measured at different times by Ellman's recycling method(0-24 h). Reactive oxidative species(ROS) levels were quantified by the dichlorofluorescein assay(0-48 h); Pyrrolidin dithiocarbamate(PDTC) was tested as an antioxidant control and H2O2 as a positive oxidant agent.RESULTS: SAM exposition decreased HCV-RNA levels 50%-70% compared to non-treated controls(24-72 h). SAM induced a synergic antiviral effect with standard IFN treatment but it was independent of IFN signaling. In addition, 1 mmol/L SAM exposition did not modify viral RNA stability, but it needs cellular translation machinery in order to decrease HCV expression. Total glutathione levels increased upon SAM treatment in HCV-replicon cells. Transcriptional antioxidant enzyme expression(SOD-1, SOD-2 and thioredoxin-1) was increased at different times but interestingly, there was no significant change in ROS levels upon SAM treatment, contrary to what was detected with PDTC treatment, where an average 40% reduction was observed in exposed cells. There was a turnover from MAT1A/MAT2 A, since MAT1 A expression was increased(2.5 fold-times at 48 h) and MAT2 A was diminished(from 24 h) upon SAM treatment at both the transcriptional and translational level. CONCLUSION: A likely mechanism(s) by which SAM diminish HCV expression could involve modulating antioxidant enzymes, restoring biosynthesis of glutathione and switching MAT1/MAT2 turnover in HCV expressing cells.

Structural insights into the distinct protective mechanisms of human antibodies targeting ZIKV NS1

Antibodies targeting non-structural protein 1(NS1)confer protection against Zika virus(ZIKV).Although monoclonal an-tibodies(MAbs)3G2 and 4B8 are more potent than MAb 4F10 in suppressing ZIKV infection in neonatal mice models,the epitopes are unclear.Herein,we determined the Cryo-electron microscopy(Cryo-EM)structures of ZIKV NS1 in com-plex withfive human antibodies at 2.6–2.9Åresolution.Group I antibodies(3G2 and 4B8)recognize the previously un-reported epitopes on the outer surface of the NS1 dimer.The unique binding mode of Group I antibodies led to a stronger recognition of the cell surface form of NS1 and completely inhibited secreted form non-structural protein 1(sNS1)-induced endothelial permeability via their immunoglobulin G(IgG)and Fab.Group II antibodies(4F10,2E11,and 14G5)recognize common epitopes in the distal end of the b-ladder domain,with a blockade efficiency that may be related to their affinity for the sNS1 protein and the presence of full-length IgG.Thesefindings elucidate the correlation between epitope recognition and protective efficacy of anti-NS1 antibodies and highlight the diagnostic and therapeutic potential of 3G2 and 4B8.

Zika virus non-structural protein 4B interacts with DHCR7 to facilitate viral infection

Zika virus(ZIKV)evolves non-structural proteins to evade immune response and ensure efficient replication in the host cells.Cholesterol metabolic enzyme 7-dehydrocholesterol reductase(DHCR7)was recently reported to impact innate immune responses in ZIKV infection.However,the vital non-structural protein and mechanisms involved in DHCR7-mediated viral evasion are not well elucidated.In this study,we demonstrated that ZIKV infection facilitated DHCR7 expression.Notably,the upregulated DHCR7 in turn facilitated ZIKV infection and blocking DHCR7 suppressed ZIKV infection.Mechanically,ZIKV non-structural protein 4B(NS4B)interacted with DHCR7 to induce DHCR7 expression.Moreover,DHCR7 inhibited TANK-binding kinase 1(TBK1)and interferon regulatory factor 3(IRF3)phosphorylation,which resulted in the reduction of interferon-beta(IFN-β)and interferon-stimulated genes(ISGs)productions.Therefore,we propose that ZIKV NS4B binds to DHCR7 to repress TBK1 and IRF3 activation,which in turn inhibits IFN-βand ISGs,and thereby facilitating ZIKV evasion.This study broadens the insights on how viral non-structural proteins antagonize innate immunity to facilitate viral infection via cholesterol metabolic enzymes and intermediates.

Splicing factor SF3B3,a NS5-binding protein,restricts ZIKV infection by targeting GCH1

Zika virus(ZIKV),a positive-sense single-stranded RNA virus,causes congenital ZIKV syndrome in children and Guillain-Barre Syndrome(GBS)in adults.ZIKV expresses nonstructural protein 5(NS5),a large protein that is essential for viral replication.ZIKV NS5 confers the ability to evade interferon(IFN)signalling;however,the exact mechanism remains unclear.In this study,we employed affinity pull-down and liquid chromatography-tandem mass spectrometry(LC-MS/MS)analyses and found that splicing factor 3b subunit 3(SF3B3)is associated with the NS5-Flag pull-down complex through interaction with NS5.Functional assays showed that SF3B3 overexpression inhibited ZIKV replication by promoting IFN-stimulated gene(ISG)expression whereas silencing of SF3B3 inhibited expression of ISGs to promote ZIKV replication.GTP cyclohydrolase I(GCH1)is the first and ratelimiting enzyme in tetrahydrobiopterin(BH4)biosynthesis.NS5 upregulates the expression of GCH1 during ZIKV infection.And GCH1 marginally promoted ZIKV replication via the IFN pathway.Additionally,GCH1 expression is related to the regulation of SF3B3.Overexpression of the SF3B3 protein effectively reduced GCH1 protein levels,whereas SF3B3 knockdown increased its levels.These findings indicated that ZIKV NS5 binding protein SF3B3 contributed to the host immune response against ZIKV replication by modulating the expression of GCH1.

Differential transcription-activating capability of NS1 proteins from different influenza virus subtypes expressed in yeast

Influenza A virus NS1 protein is an important regulatory factor with multiple functions and contributes greatly to viral pathogenesis.In the present study,transcription-activating potential of NS1 from different influenza A virus subtypes was examined in yeast two-hybrid system.The bait vectors contain-ing different NS1 genes,along with an empty prey vector,were transformed into yeast AH109(for growth assay on QDO plate and α-galactosidase assay),and Y187(for β-galactosidase assay).AH109 transformants with NS1 gene from H1N1,H5N1,and H9N2 viruses grew vigorously on the QDO plate and secreted high level of α-galactosidase.Also,Y187 bearing the above NS1 genes exhibited en-hanced β-galactosidase activity.Nevertheless,H3N2-NS1-transformed AH109 and Y187 yeasts did not grow on QDO plate and secrete β-galactosidase,respectively.These findings denote the remarkable variation in NS1 proteins from different influenza A virus subtypes on the transcription-stimulating capability in yeast.

Heterologous interactions between NS1 proteins from different influenza A virus subtypes/strains

Non-structural protein 1 （NS1） of the influenza virus plays a crucial role in modulating the host immune response and facili- tating virus replication. The formation of a homodimer or an oligomer is necessary for NSI to exert its function efficiently. In the present study, the NS 1 protein from the A/Shantou/602/06（H3N2） virus （herein abbreviated as NS32） was found to interact with NS1 from A/Shantou/169/O6（H1N1）, A/Chicken/Guangdong/1/05（HSN1） and A/Quail/Hong Kong/G1/97（H9N2） （abbre- viated as NS11, NS51 and NS92, respectively） viruses, although NS32 shares 17.4%-20.9% sequence diversity with NS11, NS51 and NS92. This indicates that the heterologous interactions between NS1 proteins from different influenza A virus sub- types/strains may be a common event during co-infection.

创建可视化的家蚕杆状病毒表达系统表达家蚕二分浓核病毒非结构蛋白NS1

重组杆状病毒感染昆虫细胞是表达外源蛋白常用的一种方法。为有效鉴定转染的细胞中是否产生了重组病毒粒子,对质粒pFastBacI进行改造,构建了极早期基因ie1启动子控制的绿色荧光蛋白egfp基因表达盒,以及多角体基因启动子控制的外源DNA的一个通用型双表达载体;通过酶切、连接的方式,将家蚕二分浓核病毒ns1基因连接到多角体启动子下游;在转座酶的介导下,该供体质粒上部分序列可转座到穿梭载体Bm-Bacmid上,进而构建可同时表达egfp和ns1基因的重组杆粒。将构建的该重组杆粒DNA转染BmN细胞,通过观察可视化的绿色荧光信号,可迅速判定转染后的细胞中重组病毒粒子产生的情况,收集转染后的细胞培养上清,将其感染BmN细胞,对感染4 d后的细胞总蛋白进行Western blotting分析,结果表明能杂交到一条36 kDa大小的特异蛋白,表明NS1蛋白成功获得了表达,进而为深入研究ns1基因的功能奠定了基础。

乙型流感病毒NS1基因的进化

NS1蛋白是由流感病毒第8个RNA片段（丙型流感病毒NS1由第7个片段）编码的RNA结合蛋白。研究表明，NS1蛋白与流感病毒宿主存在复杂的相互作用，是流感病毒主要的毒力因子。乙型流感病毒是导致流感暴发的主要病原之一，目前为止只发现一个亚型，宿主特异性较强。

细小病毒H-1 NS1基因在荷人肝癌裸小鼠几种组织及移植瘤中的转录和表达

为了解细小病毒H 1NS1基因在移植瘤与荷瘤裸小鼠部分正常组织中转录和表达的差异性 ,采用RT PCR和免疫组织化学的方法 ,对细小病毒H 1的NS1基因在NB 32 4K和QGY 770 3细胞以及荷人肝癌裸小鼠的移植瘤及部分正常组织中的转录和表达进行了检测 .NS1选择性地在人肝癌移植瘤中的高表达结果与细小病毒H 1的复制情况一致 .

热休克蛋白27增强A型流感病毒NS1对β干扰素的抑制作用

热休克蛋白27(Heat shock protein 27,HSP27)是一种具有多重功能的小热休克蛋白,它在一些病毒的生命周期中也发挥着重要作用。为研究HSP27对流感病毒感染的调节作用,首先在原核及真核细胞中克隆并表达了人源的HSP27蛋白,并验证了HSP27和A型流感病毒NS1蛋白能够相互结合。通过荧光素酶检测试验发现,HSP27可以抑制病毒感染细胞中β干扰素(IFN-β)的表达,但不依赖于其自身的磷酸化状态,而且HSP27与NS1共同对于IFN-β的表达具有叠加抑制效果。进一步的结果表明HSP27可能通过RIG-I样RNA解旋酶(RLH)途径中MDA5因子抑制IFN-β的表达。研究表明,HSP27在被感染细胞的天然免疫中发挥一定作用,有助于进一步阐明宿主因子对于流感病毒感染的调节机理。

人星状病毒非结构蛋白nsP1a／1表达纯化及多克隆抗体的制备

目的：表达纯化人星状体病毒（ human astrovirus， HAstV）非结构蛋白nsP1a／1，免疫动物制备多克隆抗体。方法利用PCR技术扩增nsP1a／1基因序列，构建到大肠埃希菌原核表达系统中表达重组nsP1a／1蛋白，使用镍柱亲和层析法对重组蛋白进行纯化，十二烷基磺酸钠-聚丙烯酰胺凝胶电泳（ SDS-PAGE）和二噻啉甲酸（BCA）实验对重组蛋白的纯度与浓度进行分析，以重组的nsP1a／1蛋白为抗原，免疫雄性SPF级SD 大鼠获得多抗血清，用 ELISA 测定抗体效价、 Western 印迹检测抗体特异性。结果nsP1a／1-pET28a原核表达载体构建成功，将其转化至大肠埃希菌BL21（DE3）细菌中诱导表达了重组蛋白，免疫大鼠获得的多抗血清几何平均效价达到1∶406374。结论本实验成功地运用原核表达系统表达并鉴定了人星状体病毒非结构蛋白nsP1a／1，为进一步研究人星状病毒的复制及病毒感染的临床诊断奠定基础。

A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice

Dengue virus(DENV)is a mosquito-borne virus with a rapid spread to humans,causing mild to potentially fatal illness in hundreds of millions of people each year.Due to the large number of serotypes of the virus,there remains an unmet need to develop protective vaccines for a broad spectrum of the virus.Here,we constructed a modified mRNA vaccine containing envelope domain III(E-DIII)and non-structural protein 1(NS1)coated with lipid nanoparticles.This multi-target vaccine induced a robust antiviral immune response and increased neutralizing antibody titers that blocked all four types of DENV infection in vitro without significant antibodydependent enhancement(ADE).In addition,there was more bias for Th1 than Th2 in the exact E-DIII and NS1-specific T cell responses after a single injection.Importantly,intramuscular immunization limited DENV transmission in vivo and eliminated vascular leakage.Our findings highlight that chimeric allogeneic structural and non-structural proteins can be effective targets for DENV vaccine and that they can prevent the further development of congenital DENV syndrome.